Research Analysts Offer Predictions for XFOR FY2027 Earnings
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Investment analysts at Brookline Capital Management cut their FY2027 EPS estimates for X4 Pharmaceuticals in a research report issued on Thursday, February 6th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings of $0.36 per share for the year, down from their […]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Investment analysts at Brookline Capital Management cut their FY2027 EPS estimates for X4 Pharmaceuticals in a research report issued on Thursday, February 6th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings of $0.36 per share for the year, down from their […]
